A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors

Clinical trial NCT01455532 · COMPLETED

Trial details

NCT number: NCT01455532
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasm Malignant

Start date: 2011-11-01
Primary completion: 2013-05-01
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.